5 Things Arizona: Health bills, Workforce shortages, HCBS spending plan
Eli Kirshbaum | Feb 3, 2022 | Arizona
Registration for '5 Slides: The policy implications of new medicines' is now open!
Nicole Pasia | Jan 27, 2022 | Florida
5 Slides We're Discussing: Overcoming Vaccine Hesitancy
Aaron Kunkler | Jan 26, 2022 | Alaska
Register now for '5 Slides: Overcoming vaccine hesitancy'
Aaron Kunkler | Jan 18, 2022 | Alaska
Registration for '5 Slides: Bending the Rx cost curve' is now open!
Emily Boerger | Jan 10, 2022 | Federal
The pandemic has shifted the politics and public opinion on health care. Where cost was a primary concern before COVID, now access to affordable innovations is top of consumers' and policy makers' minds. As a return to normalcy appears on the horizon, the intersection of cost pressures and innovation in
5 Things Michigan: Q&A w/ Rep. Whiteford, '5 Slides' video, Lobbyist on 2021 session
Eli Kirshbaum | Dec 7, 2021 | Michigan
I hope everyone had a great Thanksgiving holiday! This week's newsletter includes a conversation with Rep. Mary Whiteford on her policy priorities, our recent "5 Slides We're Watching " video on the cost of new medicines, and an interview with a health care lobbyist about some of the main themes
Video: Gene therapy and the promise for rare disease
Eli Kirshbaum | Nov 17, 2021 | California
Groundbreaking gene therapy treatments have tremendous potential to provide treatment to the around one in ten Americans living with rare diseases. But these game-changing therapies also bring with them new challenges, including how the individuals who need them most will get access to and be able to pay for these
5 Slides We're Discussing: The policy implications of new medicines
Patrick Jones | Nov 17, 2021 | Illinois, Michigan
Panelists discussed the importance of transparency and need for cost reductions on specialty drugs in State of Reform’s recent virtual conversation “5 Slides We’re Discussing: The policy implications of new medicines.” The experts called on pharmaceutical companies and pharmacy benefit managers (PBMs) to be more transparent in their pricing and
5 Things Virginia: Public comments on reinsurance waiver, Paid family & medical leave bill, Cost efficiency
Emily Boerger | Nov 17, 2021
With the Thanksgiving holiday next week, I wanted to take a moment to say thank you on behalf of the entire State of Reform team for your continued support. Whether it's through attending our conferences, reading our coverage of health care and health policy in Virginia, or sponsoring our events,
Registration for "5 Slides: The policy implications of new medicines" is now open!
Patrick Jones | Nov 3, 2021 | Illinois, Michigan
The pandemic has shifted the politics and public opinion on health care. Where cost was a primary concern before COVID, now access to affordable innovations is top of consumers and policy makers minds. So, as a return to normalcy appears on the horizon, the intersection of cost pressures and innovation